CRISPR Therapeutics (CRSP) News Today $76.78 +6.16 (+8.72%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$77.00 +0.22 (+0.29%) As of 04:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRSP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 9.5% - Time to Buy?October 8 at 2:10 PM | marketbeat.comSlow Capital Inc. Purchases 10,152 Shares of CRISPR Therapeutics AG $CRSPOctober 7 at 7:00 AM | marketbeat.comTyche Wealth Partners LLC Increases Position in CRISPR Therapeutics AG $CRSPOctober 7 at 6:37 AM | marketbeat.comCapital Advisors Inc. OK Sells 300,506 Shares of CRISPR Therapeutics AG $CRSPOctober 7 at 5:14 AM | marketbeat.comIVC Wealth Advisors LLC Makes New Investment in CRISPR Therapeutics AG $CRSPOctober 5, 2025 | marketbeat.comAlta Wealth Advisors LLC Takes Position in CRISPR Therapeutics AG $CRSPOctober 5, 2025 | marketbeat.comA Look at CRISPR Therapeutics’s (CRSP) Valuation Following First Public SyNTase Gene Editing Data RevealOctober 3, 2025 | finance.yahoo.comCRISPR Therapeutics (NASDAQ:CRSP) Hits New 1-Year High - Here's WhyOctober 3, 2025 | marketbeat.comLooking At CRISPR Therapeutics's Recent Unusual Options ActivityOctober 2, 2025 | benzinga.comCRISPR Therapeutics (NASDAQ:CRSP) Trading 8.2% Higher - What's Next?October 2, 2025 | marketbeat.comBMO Reaffirms Outperform on CRISPR Therapeutics (CRSP) After Sirius CollaborationOctober 2, 2025 | finance.yahoo.comCrispr Therapeutics to present preclinical data on AATD at ESGCT 2025October 1, 2025 | msn.comCRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and ...October 1, 2025 | markets.businessinsider.comCRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual CongressOctober 1, 2025 | globenewswire.comGot $200? 2 Healthcare Stocks to Buy and Hold ForeverOctober 1, 2025 | fool.comH.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics AG (CRSP) StockOctober 1, 2025 | insidermonkey.comCRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 29, 2025 | marketbeat.comVoya Investment Management LLC Boosts Stock Position in CRISPR Therapeutics AG $CRSPSeptember 27, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Decreases Stock Holdings in CRISPR Therapeutics AG $CRSPSeptember 26, 2025 | marketbeat.comExchange Traded Concepts LLC Acquires New Shares in CRISPR Therapeutics AG $CRSPSeptember 24, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for CRISPR Therapeutics (NASDAQ:CRSP)September 23, 2025 | marketbeat.comCrispr, Sirius announce first patient dosed in SRSD107 Phase 2 trialSeptember 22, 2025 | msn.comCRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in EuropeSeptember 22, 2025 | finance.yahoo.comBouvel Investment Partners LLC Buys 9,458 Shares of CRISPR Therapeutics AG $CRSPSeptember 21, 2025 | marketbeat.comCrispr Therapeutics AG Surges Amid Analyst PraiseSeptember 20, 2025 | msn.comJP Morgan Initiates Coverage of CRISPR Therapeutics (CRSP) with Overweight RecommendationSeptember 19, 2025 | msn.comCRISPR Therapeutics (NASDAQ:CRSP) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.September 19, 2025 | marketbeat.comCrispr Therapeutics initiated with an Overweight at JPMorganSeptember 18, 2025 | msn.comCRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospectsSeptember 18, 2025 | msn.comCathie Wood’s ARK Investment buys 340K shares of Crispr Therapeutics todaySeptember 18, 2025 | msn.comCathie Wood’s ARK Investment buys 340K shares of Crispr Therapeutics todaySeptember 18, 2025 | msn.comCathie Wood’s ARK ETF focuses on CRSP, BEAM stock buysSeptember 18, 2025 | investing.comCRISPR (CRSP) Gains Analyst Support on Sales Momentum and Pipeline ExpansionSeptember 17, 2025 | insidermonkey.comGoldman Sachs Group Inc. Sells 49,946 Shares of CRISPR Therapeutics AG $CRSPSeptember 17, 2025 | marketbeat.comHedges Asset Management LLC Reduces Holdings in CRISPR Therapeutics AG $CRSPSeptember 16, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 1,262,560 Shares of CRISPR Therapeutics AG $CRSPSeptember 16, 2025 | marketbeat.comMillennium Management LLC Buys 575,235 Shares of CRISPR Therapeutics AG $CRSPSeptember 15, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 6.8% - What's Next?September 13, 2025 | marketbeat.comCRISPR Therapeutics (CRSP): Revisiting Valuation in Light of New Clinical Data and Expanding Commercial MomentumSeptember 13, 2025 | finance.yahoo.comBayforest Capital Ltd Makes New $423,000 Investment in CRISPR Therapeutics AG $CRSPSeptember 12, 2025 | marketbeat.comCRISPR Therapeutics AG (CRSP)’s Casgevy Expands Global Adoption in 2025September 11, 2025 | msn.comCathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%September 11, 2025 | fool.comCRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025September 9, 2025 | globenewswire.comCRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comCRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 9, 2025 | seekingalpha.comRaymond James Financial Inc. Purchases 4,571 Shares of CRISPR Therapeutics AG $CRSPSeptember 9, 2025 | marketbeat.comTrexquant Investment LP Makes New $1.32 Million Investment in CRISPR Therapeutics AG $CRSPSeptember 8, 2025 | marketbeat.comCRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Hold" from BrokeragesSeptember 5, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Crispr Therapeutics AG (CRSP)September 4, 2025 | theglobeandmail.comCRISPR Therapeutics AG $CRSP Shares Sold by Baker BROS. Advisors LPSeptember 4, 2025 | marketbeat.com Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRSP Media Mentions By Week CRSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.620.63▲Average Medical News Sentiment CRSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼1112▲CRSP Articles Average Week Get the Latest News and Ratings for CRSP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Allogene Therapeutics News Axsome Therapeutics News Beam Therapeutics News Editas Medicine News KALA BIO News Moderna News Intellia Therapeutics News Vertex Pharmaceuticals News BioNTech News Teva Pharmaceutical Industries News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
